BeStock  
Stocks › Biotechnology › SANA

Sana Biotechnology SANA

US equityMarket cap rank #3398Biotechnology
$2.70 −$0.02 (-0.74%)
Market open · Oct 8, 10:00 am ET · After hours $2.80 +2.94%
Open$2.72
Prev close$2.72
Day range$2.66 – $2.73
Volume345.5K
Market cap$808.27M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong downtrend

0 bullish · 7 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-10.0%BearishTrading below the 20-day average of $3.00
Price vs 50-day average-20.6%BearishTrading below the 50-day average of $3.40
Price vs 200-day average-24.1%BearishTrading below the 200-day average of $3.56
50-day vs 200-day50d below 200dBearishThe 50-day average is below the 200-day average
RSI (14)31.6BearishMomentum leans negative
MACD (12,26,9)-0.19BearishMACD line is below its signal line
Bollinger band position1%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$3.00-10.0%
50-day SMA$3.40-20.6%
200-day SMA$3.56-24.1%

Recent price levels

LevelPrice
20-day high$3.36
20-day low$2.70
60-day high$4.22
60-day low$2.70
Upper Bollinger band$3.31
Lower Bollinger band$2.69

The 50-day average is currently 4.4% below the 200-day average — consistent with a “death cross” (bearish) configuration.

30-day volatility61.2%
Average true range6.34% of price
Max drawdown (1y)-54.7%
Volume (10d vs 90d)1.07x

Discussion

No comments yet — be the first to weigh in on SANA.

Leave a comment

Scroll to Top